Regulatory & Reimbursement
Market Pathways Scorecard: FDA Trends Edition
A graphic look at Q1 2024 approvals and review status.
Welcome to MyStrategist
Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
Start a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways
Start Trial
Start-Ups
Genascence: Pioneering Gene Therapy for Joint Diseases
Pioneers working on gene therapies for osteoarthritis and other chronic joint conditions won the prestigious OREF Award for 2024 at this year’s AAOS. One of the winners, Christopher Evans, PhD, discusses 30 years of research leading up to the founding of Genascence, which is now in clinical trials for a gene therapy for OA.
Don't Just Advertise... Strategize!
Advertise with MedTech Strategist and be seen by medtech's most influential executives.
Learn More
Business Strategies
Siemens Healthineers Paves the Way in Photon Counting CT
Siemens is out to a big lead in this revolutionary imaging market. Excerpted from our recent feature article.